| Target Price | kr32.64 |
| Price | kr19.00 |
| Potential |
71.79%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Magnora 2026 .
The average Magnora target price is kr32.64.
This is
71.79%
register free of charge
kr47.25
148.68%
register free of charge
kr29.29
54.16%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend Magnora to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Magnora stock has an average upside potential 2026 of
71.79%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million kr | 2.30 | 344.61 |
| 80.99% | 14,883.04% | |
| EBITDA Margin | -678.26% | 62.37% |
| 22.49% | 109.20% | |
| Net Margin | 25,808.70% | 62.66% |
| 1,522.26% | 99.76% |
5 Analysts have issued a sales forecast Magnora 2025 . The average Magnora sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Magnora EBITDA forecast 2025. The average Magnora EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Magnora Analysts have issued a net profit forecast 2025. The average Magnora net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 8.89 | 3.38 |
| 210.84% | 61.98% | |
| P/E | 5.62 | |
| EV/Sales | 3.03 |
5 Analysts have issued a Magnora forecast for earnings per share. The average Magnora EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


